Document is current

Article History

Received: 5 August 2024

Accepted: 8 September 2024

First Online: 14 October 2024

Declarations

:

: The Research Committee of the Johannesburg Health District approved the research protocol on 28 January 2022 (NHRD REF. NO: GP_202111_015). The University of the Witwatersrand Human Research Ethics Committee (Medical) approved the first version of study protocol on 19 January 2022 (ref M211160) and a revised, final version on 4 April 2023. The protocol was registered on ClinicalTrials.gov on 6 May 2023 with the public and scientific title “iHEART-SA Intervention Study (iHEART-SA)” (NCT05846503). All patients who visit the triage vitals room in participating clinics are invited to participate in the study by research staff situated in the vicinity of the room. Patients are provided study information and information sheets, and if they agree to participate, a written informed consent process is completed. If patients agree to participate, their medical records are reviewed for study purposes. On subsequent visits, research staff confirm if the patient would like to remain in the study.

: Consent for publication is not applicable given that no individual person’s data is included in any form.

: VCM has received investigator-initiated research grants (to the institution) and consultation fees (both unrelated to the current work) from Eli Lilly, Bayer, Gilead Sciences and ViiV. The rest of the authors have no competing interests to declare. Aaloke Mody is on the editorial board for <i>Implementation Science Communications.</i>